Previously, we have reported miRNA-377-dependent regulation of BCL-xL in venetoclax resistance in B-cell lymphoid malignancies and germinal center-type DLBCL [23]. This evidence concerns the gene BCL2L1 and diffuse large B-cell lymphoma.